Learn how to safely scope IT-OT penetration testing engagements. Discover best practices for asset inventory, risk management, passive assessment techniques, and operationally safe testing in industrial environments.

Annual pen testing fits a budget cycle but it doesn't reflect how fast manufacturing environments actually change. Learn how to set a testing cadence based on rate of change, risk tolerance, and compliance requirements.

21 CFR Part 11 and cGMP don't mention penetration testing but the controls they require depend on it. Learn how to align your pharma pen test program with regulatory requirements and prepare for FDA data integrity inspections.

R&D and GxP regulated environments have different risk profiles, compliance requirements, and testing constraints. Learn why a single unified pen test scope fails both and how to run dual-scope engagements efficiently.

Nation-state actors treat pharma like critical infrastructure targeting formulation data, synthesis routes, and clinical IP with patience and precision. Learn why standard pen testing misses this threat and what adversary simulation reveals instead.